What is NDC 36000-012?

36000-012 is the product NDC for Ondansetron Hydrochloride, Ondansetron hydrochloride 2 mg/mL solution, listed with the FDA by Baxter Healthcare Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.

Baxter Healthcare Corporation, NDC labeler code 36000. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ondansetron Hydrochloride?

76 other product NDCs are listed under this name.

Ondansetron Hydrochloride NDC 36000-012

NDC codes

FDA NDC Directory

Product NDC (as listed)36000-012Labeler and product segments. Claims need a package NDC.

Product NDC at billing width36000-0012Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
36000-012-25	3600000122536000001225	25 VIAL, SINGLE-DOSE in 1 CARTON (36000-012-25) / 2 mL in 1 VIAL, SINGLE-DOSEMarketed from Mar 13, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ondansetron Hydrochloride
Generic name (nonproprietary): ondansetron hydrochloride
Active ingredients: Ondansetron hydrochloride — 2 mg/mL
Dosage form: Solution
Route: Intramuscular, Intravenous
Labeler: Baxter Healthcare CorporationNDC labeler code 36000
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078287
Marketing start: Mar 13, 2013
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin 3 Receptor Antagonists (Mechanism)
Identifiers: Product ID 36000-012_f917f6a4-bb84-46ed-ba13-68e4c01097e6SPL ID f917f6a4-bb84-46ed-ba13-68e4c01097e6SPL set ID 729d865f-d84a-495e-9456-4bceebb6e03fRxCUI 283504, 1740467UNII NMH84OZK2BUPC 0336000012256
Pharmacologic class: Serotonin-3 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

J2405 — Injection, ondansetron hydrochloride, per 1 mg

Billing unit: 1 mg. Units on the claim = dose given ÷ 1 mg.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N436000001225 followed by a unit qualifier and the quantity

Package 36000-0012-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 30, 2025.

Indications (excerpt from the label)

Ondansetron injection is a 5-HT 3 receptor antagonist indicated for the prevention of: • nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. ( 1.1 ) • postoperative nausea and/or vomiting. ( 1.2 ) 1.1 Prevention of Nausea and Vomiting Associated With Initial and Repeat Courses of Emetogenic Cancer Chemotherapy Ondansetron injection is indicated for the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including high-dose cisplatin. Ondansetron injection is approved for patients aged 6 months and older. 1.2 Prevention of Postoperative Nausea and/or Vomiting Ondansetron injection is indi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 36000-012

What is NDC 36000-012?: 36000-012 is the product NDC for Ondansetron Hydrochloride, Ondansetron hydrochloride 2 mg/mL solution, listed with the FDA by Baxter Healthcare Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ondansetron Hydrochloride.
What is the active ingredient?: Ondansetron hydrochloride.
Who is the labeler?: Baxter Healthcare Corporation, NDC labeler code 36000. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ondansetron Hydrochloride?: 76 other product NDCs are listed under this name. See all Ondansetron Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Yes: J2405, Injection, ondansetron hydrochloride, per 1 mg. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ondansetron Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
ondansetron hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	Ipca Laboratories Limited	83980-017	83980-0017-1083980-0017-1383980-0017-97
ondansetron hydrochloride	Ondansetron hydrochloride 8 mg/1	Tablet, Film coatedOral	Ipca Laboratories Limited	83980-018	83980-0018-1083980-0018-1383980-0018-97
Ondansetron Hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	St. Mary's Medical Park Pharmacy	60760-878	60760-0878-10
Ondansetron Hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	Unit Dose Solutions, Inc.	87441-088	87441-0088-01
Ondansetron Hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	Unit Dose Solutions, Inc.	87441-064	87441-0064-01
Ondansetron Hydrochloride	Ondansetron hydrochloride 8 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-1242	67046-1242-03
Ondansetron Hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	Quality Care Products, LLC	83008-074	83008-0074-2083008-0074-30
Ondansetron Hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4145	70518-4145-0070518-4145-0170518-4145-02+3 more
Ondansetron Hydrochloride	Ondansetron hydrochloride 4 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals Inc.	68788-8651	68788-8651-0168788-8651-0268788-8651-03+2 more
Ondansetron Hydrochloride	Ondansetron hydrochloride 8 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals Inc.	68788-8582	68788-8582-0168788-8582-0268788-8582-03+2 more

All 77 Ondansetron Hydrochloride NDCs

Other NDCs under ANDA 078287

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078287
Product	Strength	Form · route	Labeler	Product NDC
Ondansetron Hydrochloride	Ondansetron hydrochloride 2 mg/mL	SolutionIntramuscular, Intravenous	Cardinal Health 107, LLC	55154-4453